{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T17:27:48Z","timestamp":1794245268349,"version":"4.9.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,5,27]],"date-time":"2019-05-27T00:00:00Z","timestamp":1558915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2019,5,27]],"date-time":"2019-05-27T00:00:00Z","timestamp":1558915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Microbiol"],"DOI":"10.1038\/s41564-019-0462-1","type":"journal-article","created":{"date-parts":[[2019,5,27]],"date-time":"2019-05-27T12:04:41Z","timestamp":1558958681000},"page":"1497-1507","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Structural basis for inhibition of Plasmodium vivax invasion by a broadly neutralizing vaccine-induced human antibody"],"prefix":"10.1038","volume":"4","author":[{"given":"Thomas. A.","family":"Rawlinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie M.","family":"Barber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Mohring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jee Sun","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varakorn","family":"Kosaisavee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2842-0360","authenticated-orcid":false,"given":"Samuel F.","family":"G\u00e9rard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel G. W.","family":"Alanine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevi\u00e8ve M.","family":"Labb\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean C.","family":"Elias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Silk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doris","family":"Quinkert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth O.","family":"Payne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7832-9824","authenticated-orcid":false,"given":"Angela M.","family":"Minassian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"R\u00e9nia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7951-0745","authenticated-orcid":false,"given":"Fran\u00e7ois H.","family":"Nosten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9070-4292","authenticated-orcid":false,"given":"Robert W.","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2870-1955","authenticated-orcid":false,"given":"Matthew K.","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9415-1357","authenticated-orcid":false,"given":"Simon J.","family":"Draper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,27]]},"reference":[{"key":"462_CR1","unstructured":"Control and Elimination of Plasmodium vivax Malaria: a Technical Brief (WHO, 2015)."},{"key":"462_CR2","doi-asserted-by":"publisher","first-page":"e1814","DOI":"10.1371\/journal.pntd.0001814","volume":"6","author":"PW Gething","year":"2012","unstructured":"Gething, P. W. et al. A long neglected world malaria map: Plasmodium vivax endemicity in 2010. PLoS Negl. Trop. Dis. 6, e1814 (2012).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"462_CR3","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1126\/science.aan1078","volume":"359","author":"J Gruszczyk","year":"2018","unstructured":"Gruszczyk, J. et al. Transferrin receptor 1 is a reticulocyte-specific receptor for Plasmodium vivax. Science 359, 48\u201355 (2018).","journal-title":"Science"},{"key":"462_CR4","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.ijpara.2017.03.001","volume":"47","author":"B Malleret","year":"2017","unstructured":"Malleret, B., Renia, L. & Russell, B. The unhealthy attraction of Plasmodium vivax to reticulocytes expressing transferrin receptor 1 (CD71). Int. J. Parasitol. 47, 379\u2013383 (2017).","journal-title":"Int. J. Parasitol."},{"key":"462_CR5","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/nature04443","volume":"439","author":"SK Singh","year":"2006","unstructured":"Singh, S. K., Hora, R., Belrhali, H., Chitnis, C. E. & Sharma, A. Structural basis for Duffy recognition by the malaria parasite Duffy-binding-like domain. Nature 439, 741\u2013744 (2006).","journal-title":"Nature"},{"key":"462_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.pt.2007.10.004","volume":"24","author":"CE Chitnis","year":"2008","unstructured":"Chitnis, C. E. & Sharma, A. Targeting the Plasmodium vivax Duffy-binding protein. Trends Parasitol. 24, 29\u201334 (2008).","journal-title":"Trends Parasitol."},{"key":"462_CR7","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1111\/j.1365-2958.2005.04523.x","volume":"55","author":"AP Singh","year":"2005","unstructured":"Singh, A. P. et al. Targeted deletion of Plasmodium knowlesi Duffy binding protein confirms its role in junction formation during invasion. Mol. Microbiol. 55, 1925\u20131934 (2005).","journal-title":"Mol. Microbiol."},{"key":"462_CR8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0166-6851(02)00017-8","volume":"121","author":"AP Singh","year":"2002","unstructured":"Singh, A. P., Puri, S. K. & Chitnis, C. E. Antibodies raised against receptor-binding domain of Plasmodium knowlesi Duffy binding protein inhibit erythrocyte invasion. Mol. Biochem. Parasitol. 121, 21\u201331 (2002).","journal-title":"Mol. Biochem. Parasitol."},{"key":"462_CR9","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1056\/NEJM197608052950602","volume":"295","author":"LH Miller","year":"1976","unstructured":"Miller, L. H., Mason, S. J., Clyde, D. F. & McGinniss, M. H. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N. Engl. J. Med. 295, 302\u2013304 (1976).","journal-title":"N. Engl. J. Med."},{"key":"462_CR10","doi-asserted-by":"publisher","first-page":"e0004222","DOI":"10.1371\/journal.pntd.0004222","volume":"9","author":"RE Howes","year":"2015","unstructured":"Howes, R. E. et al. Plasmodium vivax transmission in Africa. PLoS Negl. Trop. Dis. 9, e0004222 (2015).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"462_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-7-174","volume":"7","author":"RL Culleton","year":"2008","unstructured":"Culleton, R. L. et al. Failure to detect Plasmodium vivax in West and Central Africa by PCR species typing. Malar. J. 7, 174 (2008).","journal-title":"Malar. J."},{"key":"462_CR12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.chom.2018.06.008","volume":"24","author":"SJ Draper","year":"2018","unstructured":"Draper, S. J. et al. Malaria vaccines: recent advances and new horizons. Cell Host Microbe 24, 43\u201356 (2018).","journal-title":"Cell Host Microbe"},{"key":"462_CR13","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/nsmb.2088","volume":"18","author":"JD Batchelor","year":"2011","unstructured":"Batchelor, J. D., Zahm, J. A. & Tolia, N. H. Dimerization of Plasmodium vivax DBP is induced upon receptor binding and drives recognition of DARC. Nat. Struct. Mol. Biol. 18, 908\u2013914 (2011).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"462_CR14","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1111\/j.1365-2958.2004.04478.x","volume":"55","author":"H Choe","year":"2005","unstructured":"Choe, H. et al. Sulphated tyrosines mediate association of chemokines and Plasmodium vivax Duffy binding protein with the Duffy antigen\/receptor for chemokines (DARC). Mol. Microbiol. 55, 1413\u20131422 (2005).","journal-title":"Mol. Microbiol."},{"key":"462_CR15","doi-asserted-by":"publisher","first-page":"e1003869","DOI":"10.1371\/journal.ppat.1003869","volume":"10","author":"JD Batchelor","year":"2014","unstructured":"Batchelor, J. D. et al. Red blood cell invasion by Plasmodium vivax: structural basis for DBP engagement of DARC. PLoS Pathog. 10, e1003869 (2014).","journal-title":"PLoS Pathog."},{"key":"462_CR16","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1111\/j.1365-2958.2005.04484.x","volume":"55","author":"D Hans","year":"2005","unstructured":"Hans, D. et al. Mapping binding residues in the Plasmodium vivax domain that binds Duffy antigen during red cell invasion. Mol. Microbiol. 55, 1423\u20131434 (2005).","journal-title":"Mol. Microbiol."},{"key":"462_CR17","doi-asserted-by":"publisher","first-page":"15754","DOI":"10.1073\/pnas.0405421101","volume":"101","author":"KM VanBuskirk","year":"2004","unstructured":"VanBuskirk, K. M., Sevova, E. & Adams, J. H. Conserved residues in the Plasmodium vivax Duffy-binding protein ligand domain are critical for erythrocyte receptor recognition. Proc. Natl Acad. Sci. USA 101, 15754\u201315759 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"462_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-018-0083-3","volume":"3","author":"K Singh","year":"2018","unstructured":"Singh, K. et al. Malaria vaccine candidate based on Duffy-binding protein elicits strain transcending functional antibodies in a phase I trial. NPJ Vaccines 3, 48 (2018).","journal-title":"NPJ Vaccines"},{"key":"462_CR19","doi-asserted-by":"publisher","first-page":"e93683","DOI":"10.1172\/jci.insight.93683","volume":"2","author":"RO Payne","year":"2017","unstructured":"Payne, R. O. et al. Human vaccination against Plasmodium vivax Duffy-binding protein induces strain-transcending antibodies. JCI Insight 2, e93683 (2017).","journal-title":"JCI Insight"},{"key":"462_CR20","doi-asserted-by":"publisher","first-page":"348","DOI":"10.3389\/fimmu.2015.00348","volume":"6","author":"SC De Cassan","year":"2015","unstructured":"De Cassan, S. C. et al. Preclinical assessment of viral vectored and protein vaccines targeting the Duffy-binding protein Region II of Plasmodium vivax. Front Immunol. 6, 348 (2015).","journal-title":"Front Immunol."},{"key":"462_CR21","doi-asserted-by":"publisher","first-page":"4338","DOI":"10.1016\/j.vaccine.2008.06.010","volume":"26","author":"A Moreno","year":"2008","unstructured":"Moreno, A. et al. Preclinical assessment of the receptor-binding domain of Plasmodium vivax Duffy-binding protein as a vaccine candidate in rhesus macaques. Vaccine 26, 4338\u20134344 (2008).","journal-title":"Vaccine"},{"key":"462_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-018-2456-5","volume":"17","author":"M Bermudez","year":"2018","unstructured":"Bermudez, M., Moreno-Perez, D. A., Arevalo-Pinzon, G., Curtidor, H. & Patarroyo, M. A. Plasmodium vivax in vitro continuous culture: the spoke in the wheel. Malar. J. 17, 301 (2018).","journal-title":"Malar. J."},{"key":"462_CR23","doi-asserted-by":"publisher","first-page":"4009","DOI":"10.1128\/IAI.00158-09","volume":"77","author":"JL Cole-Tobian","year":"2009","unstructured":"Cole-Tobian, J. L. et al. Strain-specific Duffy binding protein antibodies correlate with protection against infection with homologous compared to heterologous Plasmodium vivax strains in Papua New Guinean children. Infect. Immun. 77, 4009\u20134017 (2009).","journal-title":"Infect. Immun."},{"key":"462_CR24","doi-asserted-by":"publisher","first-page":"8363","DOI":"10.1073\/pnas.0800371105","volume":"105","author":"CL King","year":"2008","unstructured":"King, C. L. et al. Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection. Proc. Natl Acad. Sci. USA 105, 8363\u20138368 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"462_CR25","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1093\/infdis\/jiw407","volume":"214","author":"VC Nicolete","year":"2016","unstructured":"Nicolete, V. C., Frischmann, S., Barbosa, S., King, C. L. & Ferreira, M. U. Naturally acquired binding-inhibitory antibodies to Plasmodium vivax Duffy binding protein and clinical immunity to malaria in rural Amazonians. J. Infect. Dis. 214, 1539\u20131546 (2016).","journal-title":"J. Infect. Dis."},{"key":"462_CR26","doi-asserted-by":"publisher","first-page":"6277","DOI":"10.1073\/pnas.1600488113","volume":"113","author":"E Chen","year":"2016","unstructured":"Chen, E. et al. Broadly neutralizing epitopes in the Plasmodium vivax vaccine candidate Duffy binding protein. Proc. Natl Acad. Sci. USA 113, 6277\u20136282 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"462_CR27","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1128\/IAI.01036-09","volume":"78","author":"P Chootong","year":"2010","unstructured":"Chootong, P. et al. Mapping epitopes of the Plasmodium vivax Duffy binding protein with naturally acquired inhibitory antibodies. Infect. Immun. 78, 1089\u20131095 (2010).","journal-title":"Infect. Immun."},{"key":"462_CR28","doi-asserted-by":"publisher","first-page":"W34","DOI":"10.1093\/nar\/gkt382","volume":"41","author":"J Ye","year":"2013","unstructured":"Ye, J., Ma, N., Madden, T. L. & Ostell, J. M. IgBLAST: an immunoglobulin variable domain sequence analysis tool. Nucleic Acids Res. 41, W34\u2013W40 (2013).","journal-title":"Nucleic Acids Res."},{"key":"462_CR29","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1080\/15321819.2012.659781","volume":"33","author":"AR Shakri","year":"2012","unstructured":"Shakri, A. R., Rizvi, M. M. & Chitnis, C. E. Development of quantitative receptor\u2013ligand binding assay for use as a tool to estimate immune responses against Plasmodium vivax Duffy binding protein Region II. J. Immunoass. Immunochem. 33, 403\u2013413 (2012).","journal-title":"J. Immunoass. Immunochem."},{"key":"462_CR30","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1073\/pnas.1216457110","volume":"110","author":"RW Moon","year":"2013","unstructured":"Moon, R. W. et al. Adaptation of the genetically tractable malaria pathogen Plasmodium knowlesi to continuous culture in human erythrocytes. Proc. Natl Acad. Sci. USA 110, 531\u2013536 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"462_CR31","unstructured":"Mohring, F. et al. Rapid and iterative genome editing in the zoonotic malaria parasite Plasmodium falciparum: new tools for P. vivax research. Preprint at https:\/\/www.biorxiv.org\/content\/10.1101\/590976v1.full (2019)."},{"key":"462_CR32","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/0092-8674(90)90295-P","volume":"63","author":"JH Adams","year":"1990","unstructured":"Adams, J. H. et al. The Duffy receptor family of Plasmodium knowlesi is located within the micronemes of invasive malaria merozoites. Cell 63, 141\u2013153 (1990).","journal-title":"Cell"},{"key":"462_CR33","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1111\/cmi.12275","volume":"16","author":"C Gruring","year":"2014","unstructured":"Gruring, C. et al. Human red blood cell-adapted Plasmodium knowlesi parasites: a new model system for malaria research. Cell Microbiol. 16, 612\u2013620 (2014).","journal-title":"Cell Microbiol."},{"key":"462_CR34","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/nature07306","volume":"455","author":"A Pain","year":"2008","unstructured":"Pain, A. et al. The genome of the simian and human malaria parasite Plasmodium knowlesi. Nature 455, 799\u2013803 (2008).","journal-title":"Nature"},{"key":"462_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-13-326","volume":"13","author":"RL Ord","year":"2014","unstructured":"Ord, R. L. et al. A malaria vaccine candidate based on an epitope of the Plasmodium falciparum RH5 protein. Malar. J. 13, 326 (2014).","journal-title":"Malar. J."},{"key":"462_CR36","doi-asserted-by":"publisher","first-page":"245","DOI":"10.4049\/jimmunol.1302045","volume":"192","author":"AD Douglas","year":"2014","unstructured":"Douglas, A. D. et al. Neutralization of Plasmodium falciparum merozoites by antibodies against PfRH5. J. Immunol. 192, 245\u2013258 (2014).","journal-title":"J. Immunol."},{"key":"462_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-3024.1987.tb00483.x","volume":"9","author":"A Saul","year":"1987","unstructured":"Saul, A. Kinetic constraints on the development of a malaria vaccine. Parasite Immunol. 9, 1\u20139 (1987).","journal-title":"Parasite Immunol."},{"key":"462_CR38","doi-asserted-by":"publisher","first-page":"e1002991","DOI":"10.1371\/journal.ppat.1002991","volume":"8","author":"AR Williams","year":"2012","unstructured":"Williams, A. R. et al. Enhancing blockade of Plasmodium falciparum erythrocyte invasion: assessing combinations of antibodies against PfRH5 and other merozoite antigens. PLoS Pathog. 8, e1002991 (2012).","journal-title":"PLoS Pathog."},{"key":"462_CR39","doi-asserted-by":"publisher","first-page":"e22944","DOI":"10.1371\/journal.pone.0022944","volume":"6","author":"T Nobrega de Sousa","year":"2011","unstructured":"Nobrega de Sousa, T., Carvalho, L. H. & Alves de Brito, C. F. Worldwide genetic variability of the Duffy binding protein: insights into Plasmodium vivax vaccine development. PLoS ONE 6, e22944 (2011).","journal-title":"PLoS ONE"},{"key":"462_CR40","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jim.2007.09.017","volume":"329","author":"T Tiller","year":"2008","unstructured":"Tiller, T. et al. Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning. J. Immunol. Methods 329, 112\u2013124 (2008).","journal-title":"J. Immunol. Methods"},{"key":"462_CR41","doi-asserted-by":"publisher","first-page":"e6441","DOI":"10.1371\/journal.pone.0006441","volume":"4","author":"J Quan","year":"2009","unstructured":"Quan, J. & Tian, J. Circular polymerase extension cloning of complex gene libraries and pathways. PLoS ONE 4, e6441 (2009).","journal-title":"PLoS ONE"},{"key":"462_CR42","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/nature06890","volume":"453","author":"J Wrammert","year":"2008","unstructured":"Wrammert, J. et al. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 453, 667\u2013671 (2008).","journal-title":"Nature"},{"key":"462_CR43","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.ijpara.2016.12.001","volume":"47","author":"J Jin","year":"2017","unstructured":"Jin, J. et al. Accelerating the clinical development of protein-based vaccines for malaria by efficient purification using a four amino acid C-terminal \u2018C-tag\u2019. Int. J. Parasitol. 47, 435\u2013446 (2017).","journal-title":"Int. J. Parasitol."},{"key":"462_CR44","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1128\/IAI.05924-11","volume":"80","author":"FB Ntumngia","year":"2012","unstructured":"Ntumngia, F. B. et al. Conserved and variant epitopes of Plasmodium vivax Duffy binding protein as targets of inhibitory monoclonal antibodies. Infect. Immun. 80, 1203\u20131208 (2012).","journal-title":"Infect. Immun."},{"key":"462_CR45","doi-asserted-by":"publisher","first-page":"e0004264","DOI":"10.1371\/journal.pntd.0004264","volume":"9","author":"JB Hostetler","year":"2015","unstructured":"Hostetler, J. B. et al. A library of Plasmodium vivax recombinant merozoite proteins reveals new vaccine candidates and protein\u2013protein interactions. PLoS Negl. Trop. Dis. 9, e0004264 (2015).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"462_CR46","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.pt.2016.11.001","volume":"33","author":"RO Payne","year":"2017","unstructured":"Payne, R. O., Griffin, P. M., McCarthy, J. S. & Draper, S. J. Plasmodium vivax controlled human malaria infection\u2014progress and prospects. Trends Parasitol. 33, 141\u2013150 (2017).","journal-title":"Trends Parasitol."},{"key":"462_CR47","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.celrep.2019.03.020","volume":"27","author":"P Rijal","year":"2019","unstructured":"Rijal, P. et al. Therapeutic monoclonal antibodies for Ebola virus infection derived from vaccinated humans. Cell Rep. 27, 172\u2013186.e7 (2019).","journal-title":"Cell Rep."},{"key":"462_CR48","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1128\/CVI.00042-09","volume":"16","author":"K Miura","year":"2009","unstructured":"Miura, K. et al. Anti-apical-membrane-antigen-1 antibody is more effective than anti-42-kilodalton-merozoite-surface-protein-1 antibody in inhibiting Plasmodium falciparum growth, as determined by the in vitro growth inhibition assay. Clin. Vaccin. Immunol. 16, 963\u2013968 (2009).","journal-title":"Clin. Vaccin. Immunol."},{"key":"462_CR49","doi-asserted-by":"publisher","first-page":"6948","DOI":"10.1128\/IAI.70.12.6948-6960.2002","volume":"70","author":"MC Kennedy","year":"2002","unstructured":"Kennedy, M. C. et al. In vitro studies with recombinant Plasmodium falciparum apical membrane antigen 1 (AMA1): production and activity of an AMA1 vaccine and generation of a multiallelic response. Infect. Immun. 70, 6948\u20136960 (2002).","journal-title":"Infect. Immun."},{"key":"462_CR50","doi-asserted-by":"publisher","first-page":"3371","DOI":"10.1007\/s00018-010-0387-6","volume":"67","author":"D Smolarek","year":"2010","unstructured":"Smolarek, D. et al. A recombinant dromedary antibody fragment (VHH or nanobody) directed against human Duffy antigen receptor for chemokines. Cell Mol. Life Sci. 67, 3371\u20133387 (2010).","journal-title":"Cell Mol. Life Sci."},{"key":"462_CR51","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ijpara.2015.08.003","volume":"46","author":"JS Cho","year":"2016","unstructured":"Cho, J. S. et al. Unambiguous determination of Plasmodium vivax reticulocyte invasion by flow cytometry. Int. J. Parasitol. 46, 31\u201339 (2016).","journal-title":"Int. J. Parasitol."},{"key":"462_CR52","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.1182\/blood-2011-04-348748","volume":"118","author":"B Russell","year":"2011","unstructured":"Russell, B. et al. A reliable ex vivo invasion assay of human reticulocytes by Plasmodium vivax. Blood 118, e74\u2013e81 (2011).","journal-title":"Blood"},{"key":"462_CR53","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1107\/S0907444909047337","volume":"66","author":"W Kabsch","year":"2010","unstructured":"Kabsch, W. XDS. Acta Crystallogr. D Biol. Crystallogr. 66, 125\u2013132 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"462_CR54","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1107\/S0907444905036693","volume":"62","author":"P Evans","year":"2006","unstructured":"Evans, P. Scaling and assessment of data quality. Acta Crystallogr. D Biol. Crystallogr. 62, 72\u201382 (2006).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"462_CR55","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","volume":"40","author":"AJ McCoy","year":"2007","unstructured":"McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658\u2013674 (2007).","journal-title":"J. Appl. Crystallogr."},{"key":"462_CR56","unstructured":"Bricogne, G. et al. Buster version 2.10.2 (Global Phasing Limited, 2017)."},{"key":"462_CR57","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."}],"container-title":["Nature Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41564-019-0462-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41564-019-0462-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41564-019-0462-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T17:53:12Z","timestamp":1733939592000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41564-019-0462-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,27]]},"references-count":57,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,9]]}},"alternative-id":["462"],"URL":"https:\/\/doi.org\/10.1038\/s41564-019-0462-1","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.736034922.793573192","asserted-by":"object"}]},"ISSN":["2058-5276"],"issn-type":[{"value":"2058-5276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,27]]},"assertion":[{"value":"23 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.G.W.A., M.K.H. and S.J.D. are named inventors on patent applications relating to malaria vaccines, mAbs and\/or immunization regimens.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}